Logo image of BROS

DUTCH BROS INC-CLASS A (BROS) Stock Analyst Ratings

NYSE:BROS - New York Stock Exchange, Inc. - US26701L1008 - Common Stock - Currency: USD

76.34  -2.82 (-3.56%)

After market: 76.34 0 (0%)

Buy % Consensus

88

ChartMill assigns a Buy % Consensus number of 88% to BROS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 85.31. This target is 11.75% above the current price.
BROS was analyzed by 19 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about BROS.
In the previous month the buy percentage consensus was at a similar level.
BROS was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.
BROS Historical Analyst RatingsBROS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -39 -35 -31 -27 -23 -19 -15 -11 -7 -3 5 10 15

Price Target & Forecast

Price Low Median Mean High 76.3454.5487.7285.31105.00 - -28.56% 14.91% 11.75% 37.54%
BROS Current Analyst RatingBROS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2025-02-28 Stifel Maintains Buy -> Buy
2025-02-13 UBS Maintains Buy -> Buy
2025-02-13 Stifel Maintains Buy -> Buy
2025-02-13 Wedbush Maintains Outperform -> Outperform
2025-02-13 JP Morgan Maintains Overweight -> Overweight
2025-02-13 TD Securities Maintains Buy -> Buy
2025-02-13 Baird Maintains Outperform -> Outperform
2025-02-13 Piper Sandler Maintains Neutral -> Neutral
2025-01-27 B of A Securities Maintains Buy -> Buy
2025-01-15 Jefferies Maintains Buy -> Buy
2025-01-10 Stifel Maintains Buy -> Buy
2025-01-07 Barclays Upgrade Equal-Weight -> Overweight
2025-01-06 Baird Upgrade Neutral -> Outperform
2024-12-19 JP Morgan Maintains Overweight -> Overweight
2024-12-16 Jefferies Maintains Trading Buy -> Buy
2024-12-06 UBS Maintains Buy -> Buy
2024-11-14 Stifel Maintains Buy -> Buy
2024-11-11 Piper Sandler Maintains Neutral -> Neutral
2024-11-08 Barclays Maintains Equal-Weight -> Equal-Weight
2024-11-07 TD Cowen Maintains Buy -> Buy
2024-11-07 UBS Maintains Buy -> Buy
2024-11-07 Wedbush Maintains Outperform -> Outperform
2024-11-07 JP Morgan Maintains Overweight -> Overweight
2024-11-07 Baird Maintains Neutral -> Neutral
2024-10-14 Wedbush Reiterate Outperform -> Outperform
2024-09-12 TD Cowen Reiterate Buy -> Buy
2024-08-19 Piper Sandler Downgrade Overweight -> Neutral
2024-08-15 UBS Upgrade Neutral -> Buy
2024-08-09 Barclays Maintains Equal-Weight -> Equal-Weight
2024-08-08 TD Cowen Maintains Buy -> Buy